18.4 Nail Abnormalities and Onychomycosis
Key Takeaways
Inspect all nails, the surrounding skin and the feet. Distinguish matrix change, nail bed separation and inflamed nail folds.
HSE AMRIC recommends sampling if antifungal treatment is planned. Confirm a dermatophyte before using the systemic regimen for dermatophyte nail infection.
A new or changing irregular pigmented band in one nail can signal melanoma, especially with periungual pigment or nail dystrophy.
Locate the nail change
Ask which nail changed first, how quickly the appearance evolved and whether there was repeated trauma, wet work, previous treatment, skin disease or immune compromise. Look at all nails, the soles, toe webs and nearby skin. Examine the plate, its attachment, surrounding folds and pigmentation. Matrix disease can alter the surface of the growing plate. Nail-bed disease can produce separation or subungual debris. The distribution helps distinguish repetitive pressure, inflammatory disease and fungal infection.
| Finding | Reason through the differential |
|---|---|
| Yellow-white thickening, crumbling or subungual debris | Consider onychomycosis, especially with tinea pedis. Trauma and psoriasis can produce a similar appearance. Sample if planning antifungal treatment. |
| Pitting, oil-drop colour change or onycholysis in someone with psoriasis | Nail psoriasis is likely, but fungal infection can coexist. Examine the skin and ask about joint symptoms. |
| Nail change confined to pressure points after new footwear | Repetitive trauma may cause thickening, separation or bleeding. Check that the pattern and course fit the history. |
| Painful lateral edge of a great toenail pressing into the skin | Consider an ingrown nail. Assess swelling, granulation, infection risk and whether footwear or cutting technique contributes. |
| Tender inflamed nail fold | Consider paronychia. Assess whether there is a collection or spreading infection. Chronic wet work and irritants can sustain inflammation. |
| Green-black colour under a lifted nail after frequent water exposure | Consider Pseudomonas overgrowth. Review the nail and exposure before treating empirically for fungus. |
| A changing dark longitudinal band in one nail, especially with irregularity or pigment on the surrounding fold | Assess promptly for nail unit melanoma. A trial of antifungal treatment should not delay specialist review. |
HSE nail problems · AAD nail melanoma signs · NCCP melanoma referral guidance
Confirm fungal infection when planning treatment
The HSE AMRIC guideline for adults distinguishes the decision to treat from the decision to use a systemic drug. Discuss symptoms, likelihood of benefit, risk of treatment failure, patient preference and comorbidities. If planning antifungal treatment, collect affected nail and subungual debris for mycology. Take full-thickness clippings from the diseased plate, as far back from the distal tip as safely practical, and include debris from under the affected area. Use the local laboratory collection procedure. Confirm a dermatophyte before using the systemic regimen. Non-dermatophyte moulds or a persistently non-responsive case may need specialist microbiology advice.
Topical therapy uses a nail formulation. Ordinary skin antifungal creams do not penetrate the nail adequately. The HSE limits topical treatment to less than half of the nail affected with no spread to the matrix or lunula. If confirmed dermatophyte infection warrants systemic treatment, first-choice oral terbinafine is 250 mg daily for adults with suitable organ function and no contraindications, typically six weeks to three months depending on the nail and response. Check baseline liver tests, renal function, interactions and the selected product's instructions. HSE advises repeat liver testing during prolonged courses, for example at four to six weeks. Use another approach in active or chronic liver disease. Discuss symptoms such as jaundice, dark urine or persistent nausea that require stopping the drug and prompt assessment.
A normal new nail grows slowly, so a residual damaged distal segment does not necessarily mean treatment failed. Review adherence, shoe pressure and coexisting tinea pedis, and treat tinea pedis to reduce reinfection. Nail infections in children need specialist advice. A person with diabetes and a red, hot or draining toe needs timely foot assessment rather than treatment as uncomplicated nail fungus.
HSE AMRIC nail guideline, October 2026 · CUH laboratory mycology instructions · HPRA oral terbinafine product information
Worked comparison. Two adults present with nail separation. One has thickened yellow great toenails and interdigital scaling. Collect nail samples if planning antifungal treatment and treat accompanying skin disease. The other has an isolated widening dark streak with irregular edges and pigment extending onto the proximal fold. Prompt specialist assessment is the priority because the appearance is concerning for nail melanoma. For a reported injury, check whether any blood spot migrates distally with nail growth and reassess if pigment persists, enlarges or the history is unclear.
A 54-year-old has thick, brittle toenails involving the matrix and would like treatment. No mycology sample has been taken. Which next step fits the current HSE adult pathway?
Start oral terbinafine immediately based on the colour alone
Use ordinary terbinafine skin cream on the plate to treat matrix disease
Take affected nail clippings and subungual debris for mycology before selecting systemic treatment
Avoid sampling because all nail thickening in adults is fungal
A 61-year-old notices a brown-black band on one thumbnail that has widened over three months. The lines are irregular and pigment extends onto the adjacent fold. What is the next step?
Begin a trial of nail lacquer for presumed fungal infection
Arrange prompt dermatology assessment for possible nail unit melanoma
Reassure because a single nail cannot be affected by melanoma
Remove the plate in primary care without specialist assessment
Sections you finish are checked off in the contents.